BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  BioDelivery Sciences to Host Conference Call and Webcast Reporting Third Quarter 2017 Financial Results on November 9

  BioDelivery Sciences announced that it will report its third quarter 2017 financial results and host a conference call and webcast at 4:30 PM Eastern Time on Thursday, November 9, 2017.

  October 30, 2017

   · 

  4 min read
• Biotech Bay

  UCLA Team Reports Positive Topline Results from Double-Blind Trial of NeuroSigma’s Non-Invasive eTNS System for Treatment of Pediatric ADHD

  The trial investigated the effects of eTNS on ADHD as the sole treatment, or “monotherapy.”

  October 30, 2017

   · 

  6 min read
• Business

  Lannett and Celgene Enter Into Settlement and License Agreement Related To Thalomid

  Lannett today announced that it has entered into a settlement and license agreement with Celgene that resolves patent infringement litigation in the U.S. related to Celgene’s Thalomid.

  October 30, 2017

   · 

  2 min read
• NeuroCog Trials Awarded NIH Grant to Validate Performance-Based Measure of Functioning in MCI Alzheimer’s Disease

  NeuroCog Trials today announced it received a 2017 Fast Track grant from the NIH to study the validation of a performance-based measure of functioning in Mild Cognitive Impairment and early ALZ’s disease using NCT’s proprietary technology, the Virtual Reality Functional Capacity Assessment Tool.

  October 30, 2017

   · 

  2 min read
• Drug Development

  FDA Grants Cosmo Pharmaceuticals Both QIDP and Fast Track Designations for Aemcolo (Rifamycin SV MMX) for Travelers’ Diarrhea

  Aries Pharmaceuticals, Cosmo’s U.S. subsidiary based in San Diego, California, will lead the commercial sales and marketing for Aemcolo in the U.S.

  October 30, 2017

   · 

  7 min read
• Business

  Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017

  Aethlon Medical today announced it will issue financial results for the second quarter fiscal year 2018 ended September 30, 2017 at 4:15pm eastern time on Thursday, November 2, 2017.

  October 30, 2017

   · 

  2 min read
• Drug Development

  Vaxart Announces Positive Safety and Immunogenicity Results for Its Oral Norovirus Vaccine in A Phase 1b Clinical Study

  The norovirus tablet vaccine was generally well tolerated in all subjects. Adverse events (AEs) were mostly mild in severity with headache as the most frequent AE.

  October 30, 2017

   · 

  7 min read
• 

  FDA

  FDA Approves Janssen’s New 10 Mg Dosing for XARELTO (Rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism

  The study shows XARELTO 10 mg reduced the risk of recurrent VTE by 74 percent.

  October 30, 2017

   · 

  16 min read
• FDA

  Allergan Receives Approval for Ozurdex (Dexamethasone Intravitreal Implant 0.7 mg) in China for the Treatment of Retinal Vein Occlusion (RVO)

  Ozurdex is the first approved intravitreal injection for RVO in China.

  October 30, 2017

   · 

  7 min read
• Cardiome Announces Commercial Launch of Xydalba in Three New European Geographies

  Cardiome today announced that it has initiated the commercial launch of Xydalba in Sweden, Finland and the Republic of Ireland.

  October 30, 2017

   · 

  7 min read